# AbbVie partners with Iambic on AI-assisted drug discovery

_Published Monday, September 21, 2026 at 10:16 AM EDT · AI, Science · Latest · Tier 2 — Notable_

AbbVie and Iambic announced a multiyear collaboration applying Iambic's drug-design models to small-molecule programs in immunology, neuroscience and oncology. Iambic will receive an upfront payment and may earn success-based milestones and tiered royalties on products from the partnership; the companies did not disclose payment amounts.

The work will use Enchant v3, a model trained on more than 6,000 molecular properties, alongside NeuralPLexer to evaluate multiple candidate characteristics. The stated goal is to test more design hypotheses in parallel, but no resulting drug candidate has yet been reported.

## Sources

- [PR Newswire](https://www.prnewswire.com/news-releases/abbvie-and-iambic-announce-collaboration-to-accelerate-ai-driven-drug-discovery-302883724.html)

---
Canonical: https://techandbusiness.org/newswire/TRiC5BFIt96eE77RbDoYOp
Published: 2026-09-21T14:16:28.536Z
Story chronology: 2026-09-21T12:00:00.000Z
Retrieved: 2026-09-21T17:28:31.360Z
Publisher: Tech & Business (techandbusiness.org)